Nautilus Biotechnology, Inc. NAUT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 190.00K | 190.00K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 190.00K | 190.00K | -- | -- | -- |
| Cost of Revenue | 15.00K | 15.00K | -- | -- | -- |
| Gross Profit | 175.00K | 175.00K | -- | -- | -- |
| SG&A Expenses | 18.59M | 18.59M | 18.97M | 19.86M | 21.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.50M | 62.97M | 64.12M | 66.84M | 71.39M |
| Operating Income | -47.31M | -62.78M | -64.12M | -66.84M | -71.39M |
| Income Before Tax | -42.95M | -42.95M | -43.51M | -45.43M | -49.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -42.95 | -42.95 | -43.51 | -45.43 | -49.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.95M | -56.52M | -57.09M | -59.00M | -62.81M |
| EBIT | -47.31M | -62.78M | -64.12M | -66.84M | -71.39M |
| EBITDA | -46.30M | -61.35M | -62.50M | -65.08M | -69.53M |
| EPS Basic | -0.46 | -0.45 | -0.45 | -0.47 | -0.50 |
| Normalized Basic EPS | -0.29 | -0.28 | -0.28 | -0.29 | -0.31 |
| EPS Diluted | -0.46 | -0.45 | -0.45 | -0.47 | -0.50 |
| Normalized Diluted EPS | -0.29 | -0.28 | -0.28 | -0.29 | -0.31 |
| Average Basic Shares Outstanding | 507.38M | 506.44M | 505.51M | 505.02M | 504.45M |
| Average Diluted Shares Outstanding | 507.38M | 506.44M | 505.51M | 505.02M | 504.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |